MedTrace Logo

Safety and Effectiveness of Biological DMARDs in Elderly Patients With Rheumatoid Arthritis

NCT01685918 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2012-09-14

No results posted yet for this study

Summary

Study objectives

1. Comparison of drug persistency rates between elderly RA patients and young RA patients with biological DMARDs
2. Analysis of discontinuation reasons \& influencing factors of drug discontinuation in elderly RA patients and young RA patients
3. Comparison of the occurrence of adverse events \& treatment outcomes between elderly RA patients and young RA patients

Conditions

Sponsors & Collaborators

Principal Investigators

  • Sang-cheol Bae, Director · Hanyang University Hospital for Rheumatic Disease

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-04-30
Primary Completion
2013-08-31
Completion
2016-08-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01685918 on ClinicalTrials.gov